Biotech Values

[pcrutch]

Ok. I just wanted to gauge the sentiment about the likelihood for any deals. Someone might be interested in buying them for the technology rights. It would be a very cheap M&A. They only have 33M shares, for anywhere in between $33M - $66M ( $1 - $2 ), they could get access to 3 drugs in large markets. Depends on how valuable these drugs really are.

Their seems to be some interest in tecarfarin in the cardiology community for it. Obviously their first major study didn't show superiority, but at least it wasn't inferior and lacked many side effects.

They also have other products in their pipeline worth discussing.

1- Budiodarone is an oral anti-arrhythmic agent in Phase 2b clinical development for the treatment of patients with atrial fibrillation. This has fairly good Phase 2b results and seems fairly marketable to a larger pharma

2- ATI-7505 also seems to have some value.